Bladder Function and Safety of Vibegron in Men With Overactive Bladder Receiving Treatment for Benign Prostatic Hyperplasia: Outcomes From the Phase 3 Randomized Controlled COURAGE Trial. [PDF]
Rovner ES +6 more
europepmc +1 more source
Encorafenib plus binimetinib versus dabrafenib plus trametinib for the first-line treatment of patients with BRAF<sup>V600E</sup>-mutant metastatic non-small cell lung cancer: a matching-adjusted indirect treatment comparison. [PDF]
Planchard D +6 more
europepmc +1 more source
Plain language review: the safety of relugolix combination therapy for advanced prostate cancer. [PDF]
La Cerda J +6 more
europepmc +1 more source
Regioselective synthesis of 2-(bromomethyl)-5-aryl-thiophene derivatives palladium (0) catalyzed suzuki cross-coupling reactions: as antithrombotic and haemolytically active molecules [PDF]
core +1 more source
Ex-situ generation of gaseous nitriles in two-chamber glassware for facile haloacetimidate synthesis. [PDF]
Akselvoll NB, Larsen JT, Pedersen CM.
europepmc +1 more source
BRAF inhibitor or BRAF/MEK inhibitor treatment for patients with metastatic BRAF V600E mutated differentiated thyroid cancer. [PDF]
Finkel I +9 more
europepmc +1 more source
Targeted treatment of hypophosphatemia with trametinib in HRAS-related mosaic RASopathy. [PDF]
Mirza A +7 more
europepmc +1 more source
Feasibility of Short-Term Redifferentiation in Patients with Radioactive Iodine-Refractory Metastatic Thyroid Cancer. [PDF]
von Hinten J +8 more
europepmc +1 more source
"Tension Chyle Leak": A Life-Threatening Sequela of Thoracic Duct Injury Following Resection of BRAF-Mutated Anaplastic Thyroid Carcinoma. [PDF]
Botros K +6 more
europepmc +1 more source
Efficacy, safety, and relapse outcomes of MAPK inhibitors in pediatric Langerhans cell histiocytosis: A real-world study. [PDF]
Tang X +5 more
europepmc +1 more source

